Évanguelos Xylinas - Concepedia

Author

Évanguelos Xylinas

Also Known As

E Xylinas, E. Xylinas, Ettore Di Trapani, Evanguelos N. Xylinas, Evanguelos XYLINAS, Evanguelos Xylinas, Evanguelos xylinas, Evanguelos. Xylinas, Florian Roghmann, Jean-François Hermieu

567

Publications

13.5K

Citations

H-Index

Concepts

All Affiliations

Université Paris Cité Assistance Publique – Hôpitaux de Paris Cornell University Hôpital Cochin Medical University of Vienna

ÉX

About

Évanguelos Xylinas is an author at Université Paris Cité specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	42	94	5.6K
2	Public Health	6	6	405
3	Engineering	5	5	317
4	Biostatistics	3	3	259
5	Health Sciences	2	2	94

Évanguelos Xylinas

178

Publications

9.5K

Citations

H-Index

Page 1

	Year	Citations
Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer Homayoun Zargar, Patrick Espiritu, Adrian Fairey, European Urology UrologyGenitourinary CancerMedicineOncologyNeoadjuvant Chemotherapy	2014	296
Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma Évanguelos Xylinas, Michael Rink, K. Eugene, European Urology UrologySurgical OncologyDistal Ureter ManagementGenitourinary CancerMedicine	2012	251
Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients Paolo Gontero, Richard Sylvester, Francesca Pisano, European Urology Prognostic FactorsUrological ResearchUrologyBacillus Calmette-guérinUrologic Cancer Epidemiology	2014	241
Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder Évanguelos Xylinas, Matthew Kent, Luis A. Kluth, British Journal of Cancer	2013	220
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling Brian D. Robinson, Panagiotis J. Vlachostergios, Bhavneet Bhinder, Nature Communications	2019	207
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort† J. Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, European Urology	2019	189
Prediction of Cancer Specific Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Development of an Optimized Postoperative Nomogram Using Decision Curve Analysis Morgan Rouprêt, Vincent Hupertan, Thomas Seisen, The Journal of Urology	2012	183
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees Alan Horwich, Marek Babjuk, Joaquim Bellmunt, Annals of Oncology UrologyGenitourinary CancerEau–esmo Consensus StatementsMedicineCancer Management	2019	180
Prediction of Intravesical Recurrence After Radical Nephroureterectomy: Development of a Clinical Decision-making Tool Évanguelos Xylinas, Luis A. Kluth, Niccolò Passoni, European Urology UrologySurgical OncologyMinimally Invasive ProcedureIntravesical RecurrenceOutcomes Research	2013	179
Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy Évanguelos Xylinas, Michael Rink, Brian D. Robinson, European Journal of Cancer Radical CystectomySurgical OncologyUrologyTumoral PathologyGenitourinary Cancer	2013	170

Page 1